Orion Pharma Limited reported earnings results for the first quarter ended September 30, 2022. For the first quarter, the company reported sales was BDT 3,914.68 million compared to BDT 1,187.73 million a year ago. Net income was BDT 169.38 million compared to BDT 70.29 million a year ago.

Basic earnings per share from continuing operations was BDT 0.72 compared to BDT 0.3 a year ago.